CEBR3F
CEBR3F operates in various business sectors.
Market Cap & Net Worth: CEBR3F (CEBR3F)
CEBR3F (SA:CEBR3F) has a market capitalization of $50.15K (R$305.40K) as of March 19, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #42299 globally and #467 in its home market, demonstrating a -3.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CEBR3F's stock price R$30.88 by its total outstanding shares 9890 (9.89K).
CEBR3F Market Cap History: 2024 to 2026
CEBR3F's market capitalization history from 2024 to 2026. Data shows growth from $25.69K to $50.15K (0.00% CAGR).
CEBR3F Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CEBR3F's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CEBR3F by Market Capitalization
Companies near CEBR3F in the global market cap rankings as of March 19, 2026.
Key companies related to CEBR3F by market ranking:
- MYRIAD GENETICS (BE:MYD): Ranked #42290 globally with a market cap of $50.07K USD ( €48.78K EUR).
- Shandong Weigao Blood (SHG:603014): Ranked #42291 globally with a market cap of $50.04K USD ( CN¥367.13K CNY).
- OUTOKUMPU (OUTA.SG) (STU:OUTA): Ranked #42300 globally with a market cap of $49.82K USD ( €48.53K EUR).
- BTLT39 (SA:BTLT39): Ranked #42301 globally with a market cap of $49.81K USD ( R$303.37K BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42290 | MYRIAD GENETICS | BE:MYD | $50.07K | €5.30 |
| #42291 | Shandong Weigao Blood | SHG:603014 | $50.04K | CN¥39.54 |
| #42300 | OUTOKUMPU (OUTA.SG) | STU:OUTA | $49.82K | €4.92 |
| #42301 | BTLT39 | SA:BTLT39 | $49.81K | R$30.41 |
CEBR3F Historical Marketcap From 2024 to 2026
Between 2024 and today, CEBR3F's market cap moved from $25.69K to $ 50.15K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$50.15K | +15.57% |
| 2025 | R$43.39K | +68.90% |
| 2024 | R$25.69K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of CEBR3F was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.15K USD |
| MoneyControl | $50.15K USD |
| MarketWatch | $50.15K USD |
| marketcap.company | $50.15K USD |
| Reuters | $50.15K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.